Increased Serum Netrin-1 Is Associated With Improved Prognosis of Ischemic Stroke: An Observational Study From CATIS

Background and Purpose— Previous experimental studies suggested that serum netrin-1 was associated with the progression of ischemic stroke. Knowledge about netrin-1 among ischemic stroke patients may provide new ideas for the prognostic assessment of ischemic stroke. The aim of this study was to investigate the association between serum netrin-1 and prognosis of ischemic stroke. Methods— Serum netrin-1 levels at baseline were measured for 3346 ischemic stroke patients from the CATIS (China Antihypertensive Trial in Acute Ischemic Stroke), and all patients were followed up at 3 months after stroke onset. The primary outcome was a combination of death and major disability (modified Rankin Scale score of ≥3) within 3 months after stroke onset. Results— Up to 3 months after stroke onset, 845 patients (25.25%) experienced death or major disability. After adjustment for baseline National Institutes of Health Stroke Scale score and other potential confounders, elevated serum netrin-1 was associated with a decreased risk of primary outcome (odds ratio, 0.65; 95% CI, 0.47–0.88; Ptrend=0.002) when 2 extreme quartiles were compared. Each SD increase of log-transformed netrin-1 was associated with 17% (95% CI, 7%–26%) decreased risk of primary outcome. Multivariable-adjusted spline regression models showed a negative linear dose-response relationship between serum netrin-1 and the risk of primary outcome (Plinearity=0.003). Adding netrin-1 quartile to a model containing conventional risk factors improved risk prediction for primary outcome (net reclassification improvement index =14.74%; P=0.002; integrated discrimination improvement =0.40%; P=0.005). Conclusions— Elevated serum netrin-1 levels were associated with improved prognosis at 3 months after ischemic stroke, suggesting that serum netrin-1 may be a potential prognostic biomarker for ischemic stroke. Further studies from other samples of ischemic stroke patients are needed to replicate our findings and to clarify the potential mechanisms. Clinical Trial Registration— URL: https://www.clinicaltrials.gov. Unique identifier: NCT01840072.

[1]  B. Cander,et al.  Effect of Serum Netrin-1 Levels on Diagnosis and Prognosis in Patients Admitted to the Emergency Service for Acute Coronary Syndrome , 2020, Cureus.

[2]  T. Acker,et al.  Endothelial Dab1 signaling orchestrates neuro-glia-vessel communication in the central nervous system , 2018, Science.

[3]  Song-Jie Liao,et al.  Netrin-1 Ameliorates Blood-Brain Barrier Impairment Secondary to Ischemic Stroke via the Activation of PI3K Pathway , 2017, Front. Neurosci..

[4]  R. Martin,et al.  Relation between serum levels of chemotaxis-related factors and the presence of coronary artery calcification as expression of subclinical atherosclerosis. , 2017, Clinical biochemistry.

[5]  R. Martin,et al.  Netrin‐1 and multiple sclerosis: a new biomarker for neuroinflammation? , 2017, European journal of neurology.

[6]  Shi-ting Li,et al.  Netrin‐1 overexpression improves neurobehavioral outcomes and reduces infarct size via inhibition of the notch1 pathway following experimental stroke , 2017, Journal of neuroscience research.

[7]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[8]  Jian Zhu,et al.  The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients , 2016, BMC Endocrine Disorders.

[9]  René M. Botnar,et al.  Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration , 2015, British journal of pharmacology.

[10]  J. Antel,et al.  Netrin 1 regulates blood-brain barrier function and neuroinflammation. , 2015, Brain : a journal of neurology.

[11]  Yilong Wang,et al.  Associations Between Estimated Glomerular Filtration Rate and Stroke Outcomes in Diabetic Versus Nondiabetic Patients , 2014, Stroke.

[12]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[13]  Jin-sheng Zeng,et al.  Netrin-1 rescues neuron loss by attenuating secondary apoptosis in ipsilateral thalamic nucleus following focal cerebral infarction in hypertensive rats , 2013, Neuroscience.

[14]  M. Ashraf,et al.  Cytoprotective and proangiogenic activity of ex-vivo netrin-1 transgene overexpression protects the heart against ischemia/reperfusion injury. , 2012, Stem cells and development.

[15]  J. Saver,et al.  Statistical Analysis of the Primary Outcome in Acute Stroke Trials , 2012, Stroke.

[16]  Guo-Yuan Yang,et al.  Netrin-1 Hyperexpression in Mouse Brain Promotes Angiogenesis and Long-Term Neurological Recovery After Transient Focal Ischemia , 2012, Stroke.

[17]  JunHuang,et al.  Netrin-1 Hyperexpression in Mouse Brain Promotes Angiogenesis and Long-Term Neurological Recovery After Transient Focal Ischemia , 2012 .

[18]  Hua Su,et al.  AAV-mediated netrin-1 overexpression increases peri-infarct blood vessel density and improves motor function recovery after experimental stroke , 2011, Neurobiology of Disease.

[19]  J. Mehta,et al.  Systemic human Netrin-1 gene delivery by adeno-associated virus type 8 alters leukocyte accumulation and atherogenesis in vivo , 2011, Gene Therapy.

[20]  R. Watts,et al.  Connecting vascular and nervous system development: angiogenesis and the blood-brain barrier. , 2010, Annual review of neuroscience.

[21]  Jun Zhang,et al.  Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism. , 2010, Journal of molecular and cellular cardiology.

[22]  V. Laudet,et al.  Inhibition of endothelial cell apoptosis by netrin-1 during angiogenesis. , 2009, Developmental cell.

[23]  B. Böttiger,et al.  Cerebral Resuscitation After Cardiocirculatory Arrest , 2009, Anesthesia and analgesia.

[24]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[25]  K. Moore,et al.  Netrin-1 inhibits leukocyte migration in vitro and in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Daniel W. Jones,et al.  Recommendations for Blood Pressure Measurement in Humans: An AHA Scientific Statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee , 2005, Journal of clinical hypertension.

[27]  I. Rooman,et al.  Netrin-1 expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells , 2003, Diabetologia.

[28]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[29]  [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.